Week of June 27, 2023 | Vol. 12, Issue 25

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

EmVenio inks deal to operate 10 community research mobile sites in UK

Fierce Biotech - Jun 20, 2023

EmVenio Research Expands Facilities in the U.K.

Contract Pharma - Jun 20, 2023

Lilly makes fresh bet on IL-17 with $2.4B acquisition of Dice Therapeutics

Fierce Biotech - Jun 20, 2023

Artbio emerges with $23M to make radioligand therapies for prostate cancer, with field still in 'early days'

Endpoints News - Jun 21, 2023

Thermo Fisher Scientific Completes Acquisition of MarqMetrix

Business Wire - Jun 21, 2023

UPMC and PharmaLogic Partner to Develop Novel Radiopharmaceuticals at New Facility in Pittsburgh

PR Newswire - Jun 21, 2023

Saudi Arabia looks to boost biopharma interest with new contract manufacturer

Endpoints News - Jun 21, 2023

EQT Private Equity to sell Ellab, following transformation into a leading validation & monitoring provider for the Biotech and Pharmaceutical industries

PR Newswire - Jun 21, 2023

Aslan outlicenses atopic dermatitis antibody in $138.5M deal

Endpoints News- Jun 22, 2023

Lupin wins approval for first US generic of Boehringer Ingelheim's COPD blockbuster Spiriva

Fierce Pharma - Jun 22, 2023

Two biotechs launch public offerings; Vaxxinity shares safety data on its Parkinson's vaccine

Endpoints News- Jun 22, 2023

Tagworks lands $65M for its take on Nobel-winning click chemistry in bid to expand ADC, radiopharma potential

Endpoints News- Jun 22, 2023

TANNER NEWS

The Benefits of Early Access Programs

Patients living with critical illnesses may require access to medicines that are unavailable to them for various reasons. Life-changing treatments might take years to pass the necessary regulatory approvals in certain countries, if at all. Tanner enables patient access to innovative medicines through the creation and implementation of early access programs. Read more.